BrainCool AB (publ): New CPT Code from AMA for Cooral® System supports Pathway to Reimbursement in the U.S.

MARKN.

BrainCool AB reports that the American Medical Association (AMA) have announced the approval of a new Current Procedural Terminology (CPT®) code for reduction of complications associated with oral mucositis in patients undergoing chemotherapy, thereby creating a clear path for reimbursement of the Cooral® System.
 
The new CPT code, an action resulted from the AMA CPT Editorial Panel’s September 21st - 23rd 2023 meeting, will become effective for use in 2024, and establishing a pathway for widespread adoption and reimbursement. Worth highlighting is that the code application was included by the CPT Committee as a ‘consent’ application. Meaning the application was approved without further discussions and a vote.
 
CEO Martin Waleij comments
-” This is a major milestone for Cooral® System, and most of all for patients suffering from oral mucositis as a result from cancer treatment. It further recognizes BrainCool’s innovative technology of Cooral® System, with the creation of a new unique procedure category”.

Datum 2023-09-22, kl 10:59
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!